HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lapo Alinari Selected Research
Lapo Alinari Research Topics
Disease
21
Neoplasms (Cancer)
07/2022 - 10/2005
20
Lymphoma (Lymphomas)
01/2022 - 08/2002
12
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 01/2009
10
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 08/2002
8
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 03/2005
7
Hodgkin Disease (Hodgkin's Disease)
04/2018 - 08/2002
6
B-Cell Lymphoma (Lymphoma, B Cell)
11/2020 - 12/2002
3
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 11/2010
3
Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 04/2018
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2011 - 07/2004
3
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2007 - 09/2005
3
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2007 - 05/2005
3
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
10/2006 - 05/2003
2
Genetic Translocation (Chromosomal Translocation)
12/2018 - 02/2012
2
T-Cell Lymphoma (Lymphoma, T Cell)
04/2010 - 05/2005
2
Pathologic Complete Response
06/2006 - 07/2004
2
Mycosis Fungoides
12/2005 - 09/2005
1
Disease Progression
04/2021
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1
Headache (Headaches)
04/2019
1
Atrial Fibrillation
04/2019
1
Infections
04/2019
1
Hemorrhage
04/2019
1
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2017
1
Epstein-Barr Virus Infections
09/2016
1
Glioblastoma (Glioblastoma Multiforme)
03/2014
1
Oral Ulcer (Mouth Ulcer)
12/2012
1
Breast Neoplasms (Breast Cancer)
09/2012
1
Leukemia
09/2012
1
B-Cell Leukemia (Leukemia, B Cell)
09/2012
1
Multiple Sclerosis
12/2011
1
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2011
1
T-Cell Leukemia (Leukemia, T Cell)
09/2009
1
Sezary Syndrome (Sezary Erythroderma)
12/2005
1
Anemia
10/2005
Drug/Important Bio-Agent (IBA)
9
Rituximab (Mabthera)
FDA Link
01/2022 - 09/2003
5
Cyclin D1
IBA
01/2020 - 06/2010
5
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
04/2009 - 10/2004
4
Proteins (Proteins, Gene)
FDA Link
11/2021 - 03/2005
4
ibrutinib
IBA
04/2021 - 04/2019
4
Monoclonal Antibodies
IBA
04/2018 - 11/2010
4
fludarabine
IBA
12/2005 - 05/2004
3
Agammaglobulinaemia Tyrosine Kinase
IBA
04/2021 - 04/2019
3
Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)
IBA
01/2021 - 03/2014
3
Arginine (L-Arginine)
FDA Link
01/2021 - 04/2015
3
Fingolimod Hydrochloride (FTY720)
FDA Link
03/2012 - 06/2010
3
milatuzumab
IBA
03/2012 - 04/2011
3
Bortezomib (Velcade)
FDA Link
06/2011 - 09/2007
3
Epirubicin (Ellence)
FDA Link
Generic
11/2008 - 08/2002
3
Ifosfamide
FDA Link
Generic
11/2008 - 08/2002
3
Etoposide (VP 16)
FDA Link
Generic
11/2008 - 08/2002
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2005 - 05/2004
2
Pharmaceutical Preparations
IBA
04/2021 - 12/2011
2
Chromatin
IBA
01/2021 - 03/2014
2
Enzymes
IBA
01/2021 - 04/2015
2
pembrolizumab
IBA
04/2018 - 09/2016
2
Ligands
IBA
09/2016 - 09/2009
1
Methotrexate (Mexate)
FDA Link
Generic
01/2022
1
NVP-BKM120
IBA
01/2022
1
Transducin
IBA
11/2021
1
KPT-9274
IBA
01/2021
1
SNX-5422
IBA
01/2021
1
Histone Deacetylases (Histone Deacetylase)
IBA
01/2021
1
Nicotinamide Phosphoribosyltransferase
IBA
01/2021
1
selinexor
IBA
11/2020
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2020
1
zanubrutinib
IBA
01/2020
1
MicroRNAs (MicroRNA)
IBA
01/2020
1
Immune Checkpoint Proteins
IBA
10/2019
1
acalabrutinib
IBA
04/2019
1
Phosphotransferases (Kinase)
IBA
12/2018
1
Oncogene Proteins (Oncogene Protein)
IBA
12/2018
1
PLX51107
IBA
01/2018
1
Immune Checkpoint Inhibitors
IBA
01/2017
1
Nivolumab
IBA
01/2017
1
Histones (Histone)
IBA
04/2015
1
Protein Synthesis Inhibitors
IBA
09/2012
1
Cyclins
IBA
09/2012
1
silvestrol
IBA
09/2012
1
Cyclin D
IBA
09/2012
1
Sphingosine
IBA
03/2012
1
NF-kappa B (NF-kB)
IBA
02/2012
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
02/2012
1
Membrane Proteins (Integral Membrane Proteins)
IBA
04/2011
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
04/2011
1
Biological Products
IBA
04/2010
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
09/2009
1
alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamide
IBA
09/2009
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2009
1
Proteasome Inhibitors
IBA
09/2007
1
Glucose (Dextrose)
FDA Link
Generic
06/2006
1
Gemcitabine
FDA Link
12/2005
1
Platinum
IBA
10/2005
1
Hemoglobins (Hemoglobin)
IBA
10/2005
Therapy/Procedure
21
Therapeutics
07/2022 - 08/2002
11
Drug Therapy (Chemotherapy)
12/2018 - 08/2002
3
Salvage Therapy
06/2006 - 02/2004
3
Radiotherapy
10/2004 - 12/2002
2
Stem Cell Transplantation
06/2016 - 11/2008
2
Autologous Transplantation
02/2004 - 05/2003